Company Update (NYSE:CRM): Top 5 Mutual Fund Holders of Salesforce.com (CRM, ORCL)

[at Investopedia] – Discover Salesforce.com’s five largest mutual fund investors and learn why it is important that four of those funds are actively managed. Read more on this. salesforce.com, inc. (CRM) , valued at $48.31B, opened this morning at $73.06. During the trading session, CRM traded between $72.19 to $73.54 with the price of the stock fluctuating between $52.60 to $82.90 over the last 52 weeks. CRM shares are currently priced at 72.00x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 16.79x earnings multiple for the same period. According to a consensus of 41 analysts, the earnings estimate of $0.23 per share would be $0.07 better than the year-ago quarter and a $0.02 sequential increase. The full-year EPS estimate is $1.01, which would be a $0.26 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $1.89 Billion. If reported, that would be a 25.17% increase over the year-ago quarter. In terms of ratings, Macquarie Initiated CRM at Outperform (Mar 4, 2016). Previously, Credit Agricole upgraded CRM from Outperform to Buy. The average price target for CRM shares by the analysts covering the stock is $88.30, which is 20.86% above where the stock opened this morning. See more in (NYSE:CRM) Similar Articles: Company Update: Salesforce.com Inc (NYSE:CRM) – Salesforce Announces General Availability of Salesforce Health Cloud — Building Patient Relationships, Not Records Company Update: Salesforce.com Inc (NYSE:CRM) – What to Look for in Salesforce.com Earnings Company Update: Salesforce.com Inc (NYSE:CRM) – Salesforce.com (CRM) Stock Gains on Box Partnership
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.